Contrary to the hypothesis that NF-κB activates LT/ST transcription in MCC cells, we did not detect binding of any NF-κB subunits (RelA, RelB, NFKB1, NFKB2) to the NCCR, nor AmpR. The gene discussed is NFKB2; the disease is Merkel cell skin cancer.